Aortic Diseases
62
22
29
18
Key Insights
Highlights
Success Rate
95% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
1.6%
1 terminated out of 62 trials
94.7%
+8.2% vs benchmark
5%
3 trials in Phase 3/4
11%
2 of 18 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 18 completed trials
Clinical Trials (62)
Identification of Genetic Causes of Calcific Aortic Valve Disease
Impact of Aortic Diseases on Quality of Life and Work Ability
Outcomes of Aortic Dissection Repair
Soft Foam Dressings for Pressure Injury Prevention of Cardiac Surgery
Development of CIRC Technologies
INFLATE Study: Investigation of the Safety and Performance of a Novel PTV Balloon in Patients Undergoing TAVI for Severe Aortic Stenosis
Effective Myocardial Protection Time of Del Nido Cardioplegia in Adult Cardiac Surgery
Use of Shockwave M5+/L6 IVL Catheter (Intravascular Lithotripsy) in Hostile and Calcified Iliac Access
Longitudinal Validation of CIRC Technologies
Intervascular Post-Market Clinical Follow-Up (PMCF) Registry
A Study to Evaluate the Safety and Effectiveness of the Rapidlink Device When Used in Patients Undergoing an Open Surgical Procedure to Repair the Aorta
Montalcino Aortic Consortium: Precision Medicine for Heritable Thoracic Aortic Disease
Cerebral Protection in Aortic Arch Surgery
Comparison of the Diagnosis Time of VET and SCL in Patients With Intraoperative Coagulopathy
PENG Block forTranscatheter Aortic Valve Implantation
Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR
Antibiotic Prophylaxis for TEVAR
Liposomal Bupivacaine/Bupivacaine in Rectus Sheath Blocks Versus Ropivacaine in Rectus Sheath Blocks And Catheters
ANATOMICAL FEASIBILITY OF BRAILE STANDARD BRANCHED ENDOGRAFT
Aortic Dissection fAlse enlarGement radIomics predictiOn